nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetohydroxamic Acid—MMP12—Matrix Metalloproteinases—MMP11—lung cancer	0.0645	0.139	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Collagen degradation—MMP11—lung cancer	0.0534	0.115	CbGpPWpGaD
Acetohydroxamic Acid—Hydroxyurea—RRM1—lung cancer	0.0325	1	CrCbGaD
Acetohydroxamic Acid—MMP12—Degradation of the extracellular matrix—MMP11—lung cancer	0.027	0.0581	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—ROS1—lung cancer	0.0236	0.0507	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Extracellular matrix organization—COL22A1—lung cancer	0.0139	0.0299	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Degradation of the extracellular matrix—ADAMTS1—lung cancer	0.0136	0.0292	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—SLIT2—lung cancer	0.0124	0.0266	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Matrix Metalloproteinases—MMP1—lung cancer	0.0123	0.0264	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—ITGB1—lung cancer	0.0121	0.026	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Extracellular matrix organization—MMP11—lung cancer	0.0113	0.0243	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—SKI—lung cancer	0.0102	0.0219	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Collagen degradation—MMP1—lung cancer	0.0102	0.0219	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Matrix Metalloproteinases—MMP2—lung cancer	0.00951	0.0205	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Collagen degradation—MMP2—lung cancer	0.00787	0.0169	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—ATF3—lung cancer	0.00755	0.0162	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Extracellular matrix organization—COL4A2—lung cancer	0.00729	0.0157	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Matrix Metalloproteinases—MMP9—lung cancer	0.00715	0.0154	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—ANXA1—lung cancer	0.00697	0.015	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Extracellular matrix organization—SDC4—lung cancer	0.00664	0.0143	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—APP—lung cancer	0.00604	0.013	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Collagen degradation—MMP9—lung cancer	0.00592	0.0127	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—JUNB—lung cancer	0.00572	0.0123	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Extracellular matrix organization—ADAMTS1—lung cancer	0.00568	0.0122	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—FOXO3—lung cancer	0.00549	0.0118	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP9—lung cancer	0.00546	0.0117	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Degradation of the extracellular matrix—MMP1—lung cancer	0.00515	0.0111	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—SRC—lung cancer	0.00504	0.0108	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—ITGB1—lung cancer	0.00483	0.0104	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—EGFR—lung cancer	0.00441	0.00949	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Extracellular matrix organization—NCAM1—lung cancer	0.00419	0.00901	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Degradation of the extracellular matrix—CDH1—lung cancer	0.00414	0.0089	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Degradation of the extracellular matrix—MMP2—lung cancer	0.00399	0.00857	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—TERT—lung cancer	0.00389	0.00837	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—MMP1—lung cancer	0.00376	0.00808	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—MET—lung cancer	0.00349	0.00749	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—RB1—lung cancer	0.00332	0.00713	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Degradation of the extracellular matrix—CASP3—lung cancer	0.00317	0.00682	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—CREBBP—lung cancer	0.00304	0.00654	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Degradation of the extracellular matrix—MMP9—lung cancer	0.003	0.00644	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—MAP2K1—lung cancer	0.0029	0.00624	CbGpPWpGaD
Acetohydroxamic Acid—Renal impairment—Irinotecan—lung cancer	0.00289	0.00575	CcSEcCtD
Acetohydroxamic Acid—Renal impairment—Gemcitabine—lung cancer	0.00282	0.0056	CcSEcCtD
Acetohydroxamic Acid—MMP12—Extracellular matrix organization—ITGB1—lung cancer	0.00278	0.00597	CbGpPWpGaD
Acetohydroxamic Acid—Decreased appetite—Pemetrexed—lung cancer	0.00277	0.00552	CcSEcCtD
Acetohydroxamic Acid—Haemolytic anaemia—Cisplatin—lung cancer	0.00277	0.00551	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Gefitinib—lung cancer	0.00276	0.00549	CcSEcCtD
Acetohydroxamic Acid—Gastrointestinal disorder—Pemetrexed—lung cancer	0.00276	0.00548	CcSEcCtD
Acetohydroxamic Acid—Fatigue—Pemetrexed—lung cancer	0.00275	0.00548	CcSEcCtD
Acetohydroxamic Acid—Gastrointestinal disorder—Gefitinib—lung cancer	0.00274	0.00545	CcSEcCtD
Acetohydroxamic Acid—Fatigue—Gefitinib—lung cancer	0.00273	0.00544	CcSEcCtD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—PTGS2—lung cancer	0.00273	0.00586	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—CXCL8—lung cancer	0.00264	0.00568	CbGpPWpGaD
Acetohydroxamic Acid—Thrombophlebitis—Paclitaxel—lung cancer	0.00259	0.00516	CcSEcCtD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—RAF1—lung cancer	0.00258	0.00554	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—CASP3—lung cancer	0.00253	0.00544	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—IL2—lung cancer	0.00253	0.00543	CbGpPWpGaD
Acetohydroxamic Acid—Asthenia—Crizotinib—lung cancer	0.00251	0.00499	CcSEcCtD
Acetohydroxamic Acid—Anorexia—Teniposide—lung cancer	0.00246	0.00491	CcSEcCtD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—CCND1—lung cancer	0.00246	0.00529	CbGpPWpGaD
Acetohydroxamic Acid—Alopecia—Vinblastine—lung cancer	0.00245	0.00488	CcSEcCtD
Acetohydroxamic Acid—Injury—Paclitaxel—lung cancer	0.00244	0.00486	CcSEcCtD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—MMP9—lung cancer	0.00239	0.00514	CbGpPWpGaD
Acetohydroxamic Acid—Alopecia—Topotecan—lung cancer	0.00238	0.00474	CcSEcCtD
Acetohydroxamic Acid—Alopecia—Erlotinib—lung cancer	0.00236	0.00469	CcSEcCtD
Acetohydroxamic Acid—Renal impairment—Paclitaxel—lung cancer	0.00236	0.00469	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Pemetrexed—lung cancer	0.00229	0.00456	CcSEcCtD
Acetohydroxamic Acid—Lethargy—Paclitaxel—lung cancer	0.00229	0.00456	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Gefitinib—lung cancer	0.00228	0.00453	CcSEcCtD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—CCND1—lung cancer	0.00225	0.00484	CbGpPWpGaD
Acetohydroxamic Acid—Decreased appetite—Teniposide—lung cancer	0.00225	0.00447	CcSEcCtD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—JUN—lung cancer	0.00225	0.00483	CbGpPWpGaD
Acetohydroxamic Acid—Ill-defined disorder—Vinblastine—lung cancer	0.00224	0.00446	CcSEcCtD
Acetohydroxamic Acid—Anaemia—Vinblastine—lung cancer	0.00223	0.00445	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Crizotinib—lung cancer	0.00222	0.00442	CcSEcCtD
Acetohydroxamic Acid—Rash—Crizotinib—lung cancer	0.0022	0.00438	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Crizotinib—lung cancer	0.0022	0.00438	CcSEcCtD
Acetohydroxamic Acid—Thrombophlebitis—Docetaxel—lung cancer	0.0022	0.00437	CcSEcCtD
Acetohydroxamic Acid—Malaise—Vinblastine—lung cancer	0.00218	0.00434	CcSEcCtD
Acetohydroxamic Acid—Ill-defined disorder—Topotecan—lung cancer	0.00218	0.00434	CcSEcCtD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—CDKN1A—lung cancer	0.00218	0.00468	CbGpPWpGaD
Acetohydroxamic Acid—Anaemia—Topotecan—lung cancer	0.00217	0.00432	CcSEcCtD
Acetohydroxamic Acid—MMP12—Extracellular matrix organization—MMP1—lung cancer	0.00216	0.00464	CbGpPWpGaD
Acetohydroxamic Acid—Feeling abnormal—Teniposide—lung cancer	0.00213	0.00424	CcSEcCtD
Acetohydroxamic Acid—Malaise—Topotecan—lung cancer	0.00212	0.00421	CcSEcCtD
Acetohydroxamic Acid—Renal failure—Irinotecan—lung cancer	0.00208	0.00415	CcSEcCtD
Acetohydroxamic Acid—Feeling hot—Doxorubicin—lung cancer	0.00208	0.00415	CcSEcCtD
Acetohydroxamic Acid—Nausea—Crizotinib—lung cancer	0.00207	0.00413	CcSEcCtD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—EP300—lung cancer	0.00207	0.00445	CbGpPWpGaD
Acetohydroxamic Acid—Abdominal discomfort—Cisplatin—lung cancer	0.00207	0.00412	CcSEcCtD
Acetohydroxamic Acid—MMP12—Extracellular matrix organization—KDR—lung cancer	0.00205	0.0044	CbGpPWpGaD
Acetohydroxamic Acid—Alopecia—Vinorelbine—lung cancer	0.00204	0.00406	CcSEcCtD
Acetohydroxamic Acid—Discomfort—Vinblastine—lung cancer	0.00203	0.00405	CcSEcCtD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—MAPK3—lung cancer	0.00203	0.00437	CbGpPWpGaD
Acetohydroxamic Acid—Renal failure—Gemcitabine—lung cancer	0.00203	0.00404	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Pemetrexed—lung cancer	0.00203	0.00404	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Gefitinib—lung cancer	0.00202	0.00401	CcSEcCtD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—SRC—lung cancer	0.00201	0.00433	CbGpPWpGaD
Acetohydroxamic Acid—Rash—Pemetrexed—lung cancer	0.00201	0.00401	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Pemetrexed—lung cancer	0.00201	0.004	CcSEcCtD
Acetohydroxamic Acid—Rash—Gefitinib—lung cancer	0.002	0.00398	CcSEcCtD
Acetohydroxamic Acid—Renal impairment—Docetaxel—lung cancer	0.002	0.00398	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Gefitinib—lung cancer	0.002	0.00398	CcSEcCtD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—MYC—lung cancer	0.00198	0.00425	CbGpPWpGaD
Acetohydroxamic Acid—Discomfort—Topotecan—lung cancer	0.00197	0.00393	CcSEcCtD
Acetohydroxamic Acid—Anxiety—Erlotinib—lung cancer	0.00197	0.00392	CcSEcCtD
Acetohydroxamic Acid—Lethargy—Docetaxel—lung cancer	0.00194	0.00386	CcSEcCtD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—EGFR—lung cancer	0.00193	0.00415	CbGpPWpGaD
Acetohydroxamic Acid—Nausea—Pemetrexed—lung cancer	0.0019	0.00377	CcSEcCtD
Acetohydroxamic Acid—Renal failure—Cisplatin—lung cancer	0.00189	0.00377	CcSEcCtD
Acetohydroxamic Acid—Nausea—Gefitinib—lung cancer	0.00188	0.00375	CcSEcCtD
Acetohydroxamic Acid—Anorexia—Vinblastine—lung cancer	0.00188	0.00374	CcSEcCtD
Acetohydroxamic Acid—Ill-defined disorder—Vinorelbine—lung cancer	0.00186	0.00371	CcSEcCtD
Acetohydroxamic Acid—Anaemia—Vinorelbine—lung cancer	0.00186	0.0037	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Teniposide—lung cancer	0.00185	0.00369	CcSEcCtD
Acetohydroxamic Acid—Anorexia—Topotecan—lung cancer	0.00183	0.00364	CcSEcCtD
Acetohydroxamic Acid—Malaise—Vinorelbine—lung cancer	0.00181	0.00361	CcSEcCtD
Acetohydroxamic Acid—Anorexia—Erlotinib—lung cancer	0.00181	0.0036	CcSEcCtD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—MYC—lung cancer	0.00181	0.00388	CbGpPWpGaD
Acetohydroxamic Acid—Palpitations—Vinorelbine—lung cancer	0.00177	0.00353	CcSEcCtD
Acetohydroxamic Acid—MMP12—Extracellular matrix organization—CDH1—lung cancer	0.00173	0.00373	CbGpPWpGaD
Acetohydroxamic Acid—Renal failure—Etoposide—lung cancer	0.00173	0.00345	CcSEcCtD
Acetohydroxamic Acid—Depression—Paclitaxel—lung cancer	0.00172	0.00343	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Vinblastine—lung cancer	0.00171	0.00341	CcSEcCtD
Acetohydroxamic Acid—Renal failure—Paclitaxel—lung cancer	0.0017	0.00338	CcSEcCtD
Acetohydroxamic Acid—Discomfort—Vinorelbine—lung cancer	0.00169	0.00336	CcSEcCtD
Acetohydroxamic Acid—Alopecia—Irinotecan—lung cancer	0.00168	0.00335	CcSEcCtD
Acetohydroxamic Acid—MMP12—Extracellular matrix organization—MMP2—lung cancer	0.00167	0.00359	CbGpPWpGaD
Acetohydroxamic Acid—Decreased appetite—Topotecan—lung cancer	0.00167	0.00332	CcSEcCtD
Acetohydroxamic Acid—Gastrointestinal disorder—Topotecan—lung cancer	0.00165	0.00329	CcSEcCtD
Acetohydroxamic Acid—Fatigue—Topotecan—lung cancer	0.00165	0.00329	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Erlotinib—lung cancer	0.00165	0.00328	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Teniposide—lung cancer	0.00164	0.00327	CcSEcCtD
Acetohydroxamic Acid—Alopecia—Gemcitabine—lung cancer	0.00164	0.00326	CcSEcCtD
Acetohydroxamic Acid—Gastrointestinal disorder—Erlotinib—lung cancer	0.00164	0.00326	CcSEcCtD
Acetohydroxamic Acid—Fatigue—Erlotinib—lung cancer	0.00163	0.00325	CcSEcCtD
Acetohydroxamic Acid—Rash—Teniposide—lung cancer	0.00163	0.00324	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Teniposide—lung cancer	0.00163	0.00324	CcSEcCtD
Acetohydroxamic Acid—Feeling abnormal—Vinblastine—lung cancer	0.00163	0.00324	CcSEcCtD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—TP53—lung cancer	0.00162	0.00349	CbGpPWpGaD
Acetohydroxamic Acid—Headache—Teniposide—lung cancer	0.00162	0.00322	CcSEcCtD
Acetohydroxamic Acid—Thrombophlebitis—Methotrexate—lung cancer	0.00158	0.00315	CcSEcCtD
Acetohydroxamic Acid—Feeling abnormal—Topotecan—lung cancer	0.00158	0.00314	CcSEcCtD
Acetohydroxamic Acid—Anorexia—Vinorelbine—lung cancer	0.00156	0.00311	CcSEcCtD
Acetohydroxamic Acid—Ill-defined disorder—Irinotecan—lung cancer	0.00154	0.00306	CcSEcCtD
Acetohydroxamic Acid—Nausea—Teniposide—lung cancer	0.00154	0.00306	CcSEcCtD
Acetohydroxamic Acid—Anaemia—Irinotecan—lung cancer	0.00153	0.00305	CcSEcCtD
Acetohydroxamic Acid—Alopecia—Cisplatin—lung cancer	0.00153	0.00304	CcSEcCtD
Acetohydroxamic Acid—Ill-defined disorder—Gemcitabine—lung cancer	0.0015	0.00298	CcSEcCtD
Acetohydroxamic Acid—Malaise—Irinotecan—lung cancer	0.00149	0.00297	CcSEcCtD
Acetohydroxamic Acid—Anaemia—Gemcitabine—lung cancer	0.00149	0.00297	CcSEcCtD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—IL6—lung cancer	0.00148	0.00319	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—TP53—lung cancer	0.00148	0.00319	CbGpPWpGaD
Acetohydroxamic Acid—Malaise—Gemcitabine—lung cancer	0.00146	0.0029	CcSEcCtD
Acetohydroxamic Acid—Renal failure—Docetaxel—lung cancer	0.00144	0.00287	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Vinorelbine—lung cancer	0.00142	0.00284	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Vinblastine—lung cancer	0.00142	0.00282	CcSEcCtD
Acetohydroxamic Acid—Gastrointestinal disorder—Vinorelbine—lung cancer	0.00142	0.00282	CcSEcCtD
Acetohydroxamic Acid—Fatigue—Vinorelbine—lung cancer	0.00141	0.00281	CcSEcCtD
Acetohydroxamic Acid—Tremor—Cisplatin—lung cancer	0.00141	0.0028	CcSEcCtD
Acetohydroxamic Acid—Alopecia—Etoposide—lung cancer	0.0014	0.00278	CcSEcCtD
Acetohydroxamic Acid—Lethargy—Methotrexate—lung cancer	0.0014	0.00278	CcSEcCtD
Acetohydroxamic Acid—Ill-defined disorder—Cisplatin—lung cancer	0.0014	0.00278	CcSEcCtD
Acetohydroxamic Acid—Discomfort—Irinotecan—lung cancer	0.00139	0.00277	CcSEcCtD
Acetohydroxamic Acid—Anaemia—Cisplatin—lung cancer	0.00139	0.00277	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Topotecan—lung cancer	0.00137	0.00274	CcSEcCtD
Acetohydroxamic Acid—Alopecia—Paclitaxel—lung cancer	0.00137	0.00273	CcSEcCtD
Acetohydroxamic Acid—Thrombophlebitis—Doxorubicin—lung cancer	0.00137	0.00273	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Erlotinib—lung cancer	0.00136	0.00271	CcSEcCtD
Acetohydroxamic Acid—Discomfort—Gemcitabine—lung cancer	0.00136	0.0027	CcSEcCtD
Acetohydroxamic Acid—Malaise—Cisplatin—lung cancer	0.00136	0.0027	CcSEcCtD
Acetohydroxamic Acid—Feeling abnormal—Vinorelbine—lung cancer	0.00135	0.00269	CcSEcCtD
Acetohydroxamic Acid—MMP12—Extracellular matrix organization—CASP3—lung cancer	0.00133	0.00286	CbGpPWpGaD
Acetohydroxamic Acid—Tension—Paclitaxel—lung cancer	0.00133	0.00264	CcSEcCtD
Acetohydroxamic Acid—Nervousness—Paclitaxel—lung cancer	0.00131	0.00261	CcSEcCtD
Acetohydroxamic Acid—Anorexia—Irinotecan—lung cancer	0.00129	0.00257	CcSEcCtD
Acetohydroxamic Acid—Ill-defined disorder—Etoposide—lung cancer	0.00128	0.00254	CcSEcCtD
Acetohydroxamic Acid—Anxiety—Cisplatin—lung cancer	0.00128	0.00254	CcSEcCtD
Acetohydroxamic Acid—Anaemia—Etoposide—lung cancer	0.00127	0.00253	CcSEcCtD
Acetohydroxamic Acid—Tremor—Paclitaxel—lung cancer	0.00127	0.00252	CcSEcCtD
Acetohydroxamic Acid—Discomfort—Cisplatin—lung cancer	0.00127	0.00252	CcSEcCtD
Acetohydroxamic Acid—Anorexia—Gemcitabine—lung cancer	0.00126	0.0025	CcSEcCtD
Acetohydroxamic Acid—MMP12—Extracellular matrix organization—MMP9—lung cancer	0.00126	0.0027	CbGpPWpGaD
Acetohydroxamic Acid—Vomiting—Vinblastine—lung cancer	0.00125	0.0025	CcSEcCtD
Acetohydroxamic Acid—Ill-defined disorder—Paclitaxel—lung cancer	0.00125	0.0025	CcSEcCtD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—AKT1—lung cancer	0.00125	0.00269	CbGpPWpGaD
Acetohydroxamic Acid—Anaemia—Paclitaxel—lung cancer	0.00125	0.00249	CcSEcCtD
Acetohydroxamic Acid—Renal impairment—Doxorubicin—lung cancer	0.00125	0.00248	CcSEcCtD
Acetohydroxamic Acid—Malaise—Etoposide—lung cancer	0.00124	0.00247	CcSEcCtD
Acetohydroxamic Acid—Headache—Vinblastine—lung cancer	0.00124	0.00246	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Topotecan—lung cancer	0.00122	0.00243	CcSEcCtD
Acetohydroxamic Acid—Malaise—Paclitaxel—lung cancer	0.00122	0.00242	CcSEcCtD
Acetohydroxamic Acid—Lethargy—Doxorubicin—lung cancer	0.00121	0.00241	CcSEcCtD
Acetohydroxamic Acid—Rash—Topotecan—lung cancer	0.00121	0.0024	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Topotecan—lung cancer	0.00121	0.0024	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Erlotinib—lung cancer	0.00121	0.0024	CcSEcCtD
Acetohydroxamic Acid—Headache—Topotecan—lung cancer	0.0012	0.00239	CcSEcCtD
Acetohydroxamic Acid—Rash—Erlotinib—lung cancer	0.0012	0.00238	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Erlotinib—lung cancer	0.00119	0.00238	CcSEcCtD
Acetohydroxamic Acid—Palpitations—Paclitaxel—lung cancer	0.00119	0.00238	CcSEcCtD
Acetohydroxamic Acid—Headache—Erlotinib—lung cancer	0.00119	0.00236	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Vinorelbine—lung cancer	0.00118	0.00234	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Irinotecan—lung cancer	0.00118	0.00234	CcSEcCtD
Acetohydroxamic Acid—Nausea—Vinblastine—lung cancer	0.00117	0.00233	CcSEcCtD
Acetohydroxamic Acid—Anorexia—Cisplatin—lung cancer	0.00117	0.00233	CcSEcCtD
Acetohydroxamic Acid—Gastrointestinal disorder—Irinotecan—lung cancer	0.00117	0.00232	CcSEcCtD
Acetohydroxamic Acid—Fatigue—Irinotecan—lung cancer	0.00117	0.00232	CcSEcCtD
Acetohydroxamic Acid—Alopecia—Docetaxel—lung cancer	0.00116	0.00231	CcSEcCtD
Acetohydroxamic Acid—Discomfort—Etoposide—lung cancer	0.00116	0.00231	CcSEcCtD
Acetohydroxamic Acid—Anxiety—Paclitaxel—lung cancer	0.00115	0.00228	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Gemcitabine—lung cancer	0.00114	0.00228	CcSEcCtD
Acetohydroxamic Acid—Nausea—Topotecan—lung cancer	0.00114	0.00227	CcSEcCtD
Acetohydroxamic Acid—Gastrointestinal disorder—Gemcitabine—lung cancer	0.00114	0.00226	CcSEcCtD
Acetohydroxamic Acid—Discomfort—Paclitaxel—lung cancer	0.00114	0.00226	CcSEcCtD
Acetohydroxamic Acid—Abdominal discomfort—Methotrexate—lung cancer	0.00114	0.00226	CcSEcCtD
Acetohydroxamic Acid—Fatigue—Gemcitabine—lung cancer	0.00114	0.00226	CcSEcCtD
Acetohydroxamic Acid—Nausea—Erlotinib—lung cancer	0.00113	0.00224	CcSEcCtD
Acetohydroxamic Acid—Feeling abnormal—Irinotecan—lung cancer	0.00111	0.00222	CcSEcCtD
Acetohydroxamic Acid—Feeling abnormal—Gemcitabine—lung cancer	0.00109	0.00216	CcSEcCtD
Acetohydroxamic Acid—Anorexia—Etoposide—lung cancer	0.00107	0.00213	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Cisplatin—lung cancer	0.00107	0.00212	CcSEcCtD
Acetohydroxamic Acid—Gastrointestinal disorder—Cisplatin—lung cancer	0.00106	0.00211	CcSEcCtD
Acetohydroxamic Acid—Anaemia—Docetaxel—lung cancer	0.00106	0.00211	CcSEcCtD
Acetohydroxamic Acid—Depression—Methotrexate—lung cancer	0.00105	0.0021	CcSEcCtD
Acetohydroxamic Acid—Anorexia—Paclitaxel—lung cancer	0.00105	0.00209	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Vinorelbine—lung cancer	0.00104	0.00207	CcSEcCtD
Acetohydroxamic Acid—Renal failure—Methotrexate—lung cancer	0.00104	0.00207	CcSEcCtD
Acetohydroxamic Acid—Rash—Vinorelbine—lung cancer	0.00103	0.00206	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Vinorelbine—lung cancer	0.00103	0.00206	CcSEcCtD
Acetohydroxamic Acid—Headache—Vinorelbine—lung cancer	0.00103	0.00204	CcSEcCtD
Acetohydroxamic Acid—Palpitations—Docetaxel—lung cancer	0.00101	0.00201	CcSEcCtD
Acetohydroxamic Acid—Feeling abnormal—Cisplatin—lung cancer	0.00101	0.00201	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Etoposide—lung cancer	0.000977	0.00195	CcSEcCtD
Acetohydroxamic Acid—Nausea—Vinorelbine—lung cancer	0.000974	0.00194	CcSEcCtD
Acetohydroxamic Acid—Gastrointestinal disorder—Etoposide—lung cancer	0.000971	0.00193	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Irinotecan—lung cancer	0.00097	0.00193	CcSEcCtD
Acetohydroxamic Acid—Fatigue—Etoposide—lung cancer	0.000969	0.00193	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Paclitaxel—lung cancer	0.000958	0.00191	CcSEcCtD
Acetohydroxamic Acid—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000952	0.00189	CcSEcCtD
Acetohydroxamic Acid—Fatigue—Paclitaxel—lung cancer	0.000951	0.00189	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Gemcitabine—lung cancer	0.000945	0.00188	CcSEcCtD
Acetohydroxamic Acid—Feeling abnormal—Etoposide—lung cancer	0.000927	0.00184	CcSEcCtD
Acetohydroxamic Acid—Feeling abnormal—Paclitaxel—lung cancer	0.000909	0.00181	CcSEcCtD
Acetohydroxamic Acid—Renal failure—Doxorubicin—lung cancer	0.000899	0.00179	CcSEcCtD
Acetohydroxamic Acid—Anorexia—Docetaxel—lung cancer	0.000891	0.00177	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Cisplatin—lung cancer	0.000881	0.00175	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Irinotecan—lung cancer	0.00086	0.00171	CcSEcCtD
Acetohydroxamic Acid—Rash—Irinotecan—lung cancer	0.000852	0.0017	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Irinotecan—lung cancer	0.000852	0.0017	CcSEcCtD
Acetohydroxamic Acid—Headache—Irinotecan—lung cancer	0.000847	0.00169	CcSEcCtD
Acetohydroxamic Acid—Alopecia—Methotrexate—lung cancer	0.000838	0.00167	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Gemcitabine—lung cancer	0.000837	0.00167	CcSEcCtD
Acetohydroxamic Acid—Rash—Gemcitabine—lung cancer	0.00083	0.00165	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Gemcitabine—lung cancer	0.00083	0.00165	CcSEcCtD
Acetohydroxamic Acid—Headache—Gemcitabine—lung cancer	0.000825	0.00164	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Docetaxel—lung cancer	0.000812	0.00162	CcSEcCtD
Acetohydroxamic Acid—Gastrointestinal disorder—Docetaxel—lung cancer	0.000807	0.00161	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Etoposide—lung cancer	0.000807	0.00161	CcSEcCtD
Acetohydroxamic Acid—Fatigue—Docetaxel—lung cancer	0.000806	0.0016	CcSEcCtD
Acetohydroxamic Acid—Nausea—Irinotecan—lung cancer	0.000803	0.0016	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Paclitaxel—lung cancer	0.000791	0.00157	CcSEcCtD
Acetohydroxamic Acid—Nausea—Gemcitabine—lung cancer	0.000782	0.00156	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Cisplatin—lung cancer	0.00078	0.00155	CcSEcCtD
Acetohydroxamic Acid—Rash—Cisplatin—lung cancer	0.000774	0.00154	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Cisplatin—lung cancer	0.000773	0.00154	CcSEcCtD
Acetohydroxamic Acid—Feeling abnormal—Docetaxel—lung cancer	0.00077	0.00153	CcSEcCtD
Acetohydroxamic Acid—Ill-defined disorder—Methotrexate—lung cancer	0.000766	0.00152	CcSEcCtD
Acetohydroxamic Acid—Anaemia—Methotrexate—lung cancer	0.000763	0.00152	CcSEcCtD
Acetohydroxamic Acid—Malaise—Methotrexate—lung cancer	0.000744	0.00148	CcSEcCtD
Acetohydroxamic Acid—Nausea—Cisplatin—lung cancer	0.000729	0.00145	CcSEcCtD
Acetohydroxamic Acid—Alopecia—Doxorubicin—lung cancer	0.000725	0.00144	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Etoposide—lung cancer	0.000715	0.00142	CcSEcCtD
Acetohydroxamic Acid—Rash—Etoposide—lung cancer	0.000709	0.00141	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Etoposide—lung cancer	0.000708	0.00141	CcSEcCtD
Acetohydroxamic Acid—Headache—Etoposide—lung cancer	0.000704	0.0014	CcSEcCtD
Acetohydroxamic Acid—Tension—Doxorubicin—lung cancer	0.000701	0.0014	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Paclitaxel—lung cancer	0.000701	0.0014	CcSEcCtD
Acetohydroxamic Acid—Rash—Paclitaxel—lung cancer	0.000695	0.00138	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Paclitaxel—lung cancer	0.000695	0.00138	CcSEcCtD
Acetohydroxamic Acid—Discomfort—Methotrexate—lung cancer	0.000694	0.00138	CcSEcCtD
Acetohydroxamic Acid—Nervousness—Doxorubicin—lung cancer	0.000694	0.00138	CcSEcCtD
Acetohydroxamic Acid—Headache—Paclitaxel—lung cancer	0.000691	0.00137	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Docetaxel—lung cancer	0.00067	0.00133	CcSEcCtD
Acetohydroxamic Acid—Nausea—Etoposide—lung cancer	0.000668	0.00133	CcSEcCtD
Acetohydroxamic Acid—Ill-defined disorder—Doxorubicin—lung cancer	0.000663	0.00132	CcSEcCtD
Acetohydroxamic Acid—Anaemia—Doxorubicin—lung cancer	0.00066	0.00131	CcSEcCtD
Acetohydroxamic Acid—Nausea—Paclitaxel—lung cancer	0.000655	0.0013	CcSEcCtD
Acetohydroxamic Acid—Malaise—Doxorubicin—lung cancer	0.000644	0.00128	CcSEcCtD
Acetohydroxamic Acid—Anorexia—Methotrexate—lung cancer	0.000642	0.00128	CcSEcCtD
Acetohydroxamic Acid—Palpitations—Doxorubicin—lung cancer	0.000632	0.00126	CcSEcCtD
Acetohydroxamic Acid—Anxiety—Doxorubicin—lung cancer	0.000606	0.00121	CcSEcCtD
Acetohydroxamic Acid—Discomfort—Doxorubicin—lung cancer	0.000601	0.0012	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Docetaxel—lung cancer	0.000594	0.00118	CcSEcCtD
Acetohydroxamic Acid—Rash—Docetaxel—lung cancer	0.000589	0.00117	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Docetaxel—lung cancer	0.000589	0.00117	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Methotrexate—lung cancer	0.000585	0.00117	CcSEcCtD
Acetohydroxamic Acid—Headache—Docetaxel—lung cancer	0.000585	0.00117	CcSEcCtD
Acetohydroxamic Acid—Gastrointestinal disorder—Methotrexate—lung cancer	0.000581	0.00116	CcSEcCtD
Acetohydroxamic Acid—Fatigue—Methotrexate—lung cancer	0.000581	0.00116	CcSEcCtD
Acetohydroxamic Acid—Anorexia—Doxorubicin—lung cancer	0.000556	0.00111	CcSEcCtD
Acetohydroxamic Acid—Nausea—Docetaxel—lung cancer	0.000555	0.0011	CcSEcCtD
Acetohydroxamic Acid—Feeling abnormal—Methotrexate—lung cancer	0.000555	0.0011	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Doxorubicin—lung cancer	0.000507	0.00101	CcSEcCtD
Acetohydroxamic Acid—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000504	0.001	CcSEcCtD
Acetohydroxamic Acid—Fatigue—Doxorubicin—lung cancer	0.000503	0.001	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Methotrexate—lung cancer	0.000483	0.000962	CcSEcCtD
Acetohydroxamic Acid—Feeling abnormal—Doxorubicin—lung cancer	0.000481	0.000957	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Methotrexate—lung cancer	0.000428	0.000852	CcSEcCtD
Acetohydroxamic Acid—Rash—Methotrexate—lung cancer	0.000425	0.000845	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Methotrexate—lung cancer	0.000424	0.000845	CcSEcCtD
Acetohydroxamic Acid—Headache—Methotrexate—lung cancer	0.000422	0.00084	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Doxorubicin—lung cancer	0.000418	0.000833	CcSEcCtD
Acetohydroxamic Acid—Nausea—Methotrexate—lung cancer	0.0004	0.000796	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Doxorubicin—lung cancer	0.000371	0.000738	CcSEcCtD
Acetohydroxamic Acid—Rash—Doxorubicin—lung cancer	0.000368	0.000732	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Doxorubicin—lung cancer	0.000367	0.000731	CcSEcCtD
Acetohydroxamic Acid—Headache—Doxorubicin—lung cancer	0.000365	0.000727	CcSEcCtD
Acetohydroxamic Acid—Nausea—Doxorubicin—lung cancer	0.000346	0.00069	CcSEcCtD
